Korean J Psychopharmacol.  2002 Jun;13(2):85-94.

Pharmacogenomics of Antipsychotic Drugs

Affiliations
  • 1Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine,Seoul, Korea. cykim@amc.seoul.kr

Abstract

There is a substantial variation in the treatment response and adverse reactions to antipsychotic drugs. Pharmacogenomics of antipsychotic drugs is to identify the gene(s) related with this variability in outcome to antipsychotic drugs. The genes considered to be related with the mechanism of action of antipsychotic drugs have been focused in this field, such as cytochrome P450, serotonin receptors, and dopamine receptors genes. Pharmacogenomic studies dealing with antipsychotic drugs have aimed to identify the association of these genes and drug response and adverse reactions. In this paper, the concept, methodological considerations, and future prospect of pharmacogenomics related with antipsychotic drugs will be addressed with extensive review of literatures.

Keyword

Antipsychotic drug; Pharmacogenomics; Pharmacogenetics

MeSH Terms

Antipsychotic Agents*
Cytochrome P-450 Enzyme System
Pharmacogenetics*
Receptors, Dopamine
Receptors, Serotonin
Antipsychotic Agents
Cytochrome P-450 Enzyme System
Receptors, Dopamine
Receptors, Serotonin
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr